https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-of-the-drug-tebentafusp-for-melanoma-tebemrd
A study of the drug tebentafusp for melanoma (TebeMRD)
This study is looking at a type of immunotherapy called tebentafusp. It is for people with melanoma of the skin (cutaneous), or of the eye (uveal).
a studyof thedrugtebentafuspmelanoma
https://www.adnkronos.com/salute/melanoma-uveale-metastatico-tebentafusp-raddoppia-sopravvivenza-a-5-anni_7qHg1ZQmhVOah6xgbINQH9
Melanoma uveale metastatico: "Tebentafusp raddoppia sopravvivenza a 5 anni"
Dati di fase 3 al congresso Aacr: 'Con trattamento in prima linea beneficio in termini di sopravvivenza globale in tutti i principali sottogruppi di pazienti'
a 5melanomatebentafuspsopravvivenzaanni
https://www.mayoclinic.org/es/drugs-supplements/tebentafusp-tebn-intravenous-route/description/drg-20529404
Tebentafusp-tebn (intravenous route) - Side effects & uses - Mayo Clinic
tebentafusp tebnintravenous routeside effectsusesmayo
https://www.jci.org/articles/view/181464
JCI - Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal...
https://www.medicines.org.uk/emc/product/13842/smpc
KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusion - Summary of...
KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusion - Summary of Product Characteristics (SmPC) by Immunocore Limited
kimmtraktebentafusp200microgramsml